1238891-40-1

Basic information

• Product Name: 6-{1-[(3S,4S)-1-Benzyl-3-(4-chloro-phenyl)-piperidin-4-yl]-ethylamino}-nicotinonitrile
• Synonyms: 6-{1-[(3S,4S)-1-Benzyl-3-(4-chloro-phenyl)-piperidin-4-yl]-ethylamino}-nicotinonitrile
• CAS NO: 1238891-40-1
• Molecular Weight: 430.98
• Mol File: 1238891-40-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-{1-[(3S,4S)-1-Benzyl-3-(4-chloro-phenyl)-piperidin-4-yl]-ethylamino}-nicotinonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 6-{1-[(3S,4S)-1-Benzyl-3-(4-chloro-phenyl)-piperidin-4-yl]-ethylamino}-nicotinonitrile(1238891-40-1)
• EPA Substance Registry System: 6-{1-[(3S,4S)-1-Benzyl-3-(4-chloro-phenyl)-piperidin-4-yl]-ethylamino}-nicotinonitrile(1238891-40-1)

Safety Data

• Hazardous Substances Data: 1238891-40-1(Hazardous Substances Data)

Upstream product

• 1238891-39-8 1-[(3S,4S)-1-Benzyl-3-(4-chloro-phenyl)-piperidin-4-yl]-ethylamine 
• 139585-70-9 2-bromo-5-cyanopyridine 

Relevant articles and documents

PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS

The present invention relates to a compounds of formula I wherein A, Ar1, Ar2, R1, R2, R3, R4, R5, R6, m, n, o, p, s, t, and u are as defined herein or to a pharmaceutically active salt, a racemic mixture, an enantiomer, an optical isomer or a tautomeric form thereof. the present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).